Clinical features, etiology, and outcomes of community-acquired pneumonia in patients with diabetes mellitus

Medicine (United States)

Volumn 92, Issue 1, 2013, Pages 42-50

  Di Yacovo, Silvana ^a   Garcia Vidal, Carolina ^a,b   Viasus, Diego ^a,b   Adamuz, Jordi ^a   Oriol, Isabel ^a   Gili, Francesca ^a   Vilarrasa, Núria ^a   García Somoza, M Dolors ^a   Dorca, Jordi ^a,b   Carratalà, Jordi ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CARDIOVASCULAR AGENT; CEFTRIAXONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LEVOFLOXACIN;

ADULT; AGED; ARTICLE; BACTEREMIA; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; COUGHING; DIABETES MELLITUS; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOCOMPROMISED PATIENT; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORTALITY; MULTIPLE ORGAN FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEPTIC SHOCK; SPUTUM; THORAX PAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; DIABETES MELLITUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN; STATISTICS, NONPARAMETRIC;

EID: 84871924202     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e31827f602a     Document Type: Article

References (38)

1. American Diabetes Association. Diagnosis and classification ofdiabetes mellitus. Diabetes Care. 2012;35(Suppl 1):S64YS71.
2. American Diabetes Association. Standards of medical care in diabetes.Diabetes Care. 2012;35(Suppl 1):S11YS63.
3. Bader MS, Abouchehade KA, Yi Y, Haroon B, Bishop LD, Hawboldt J.Antibiotic administration longer than eight hours after triage andmortality of community-acquired pneumonia in patients with diabetesmellitus. Eur J Clin Microbiol Infect Dis. 2011;30:881-886.
4. Benfield T, Jensen JS, Nordestgaard G. Influence of diabetes andhyperglycaemia on infectious disease hospitalization and outcomes. Diabetologia. 2007;50:549-554. (Pubitemid 46215497)
5. Carratala J, Garcia-Vidal C. Update on Legionella. Curr Opin InfectDis. 2010;23:152-157.
6. Chalmers JD, Singanayagam A, Murray MP, Hill AT. Prior statin use isassociated with improved outcomes in community-acquiredpneumonia. Am J Med. 2008;121:1002-1007.
7. Delamaire M, Maugendre D, Moreno M, Le goff MC, Allannic H,Genetet B. Impaired leucocyte functions in diabetic patients. DiabetMed. 1997;14:29-34. (Pubitemid 27019919)
8. Dominguez A, Izquierdo C, Salleras L, Ruiz L, Sousa D, Bayas JM,Nebot M, Varona W, Celorrio JM, Carratala J; for the Working Groupfor the Study of Prevention of CAP in the Elderly. Effectiveness of thepneumococcal polysaccharide vaccine in preventing pneumonia inthe elderly. Eur Respir J. 2010;36:608-614.
9. Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S,Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH,Mukamal KJ, Gillum RF, Holme I, Njølstad I, Fletcher A, Nilsson P,Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E,Hu FB, Danesh J. Diabetes mellitus, fasting glucose, and risk ofcause-specific death. N Engl J Med. 2011;364:1281.
10. Falguera M, Carratala J, Bielsa S, Garcia-Vidal C, Ruiz-Gonzalez A,Chica I, Gudiol F, Porcel JM. Predictive factors, microbiology andoutcome of patients with parapneumonic effusion. Eur Respir J.2011;38:1173-1179.
11. Falguera M, Pifarre R, Martin A, Sheikh A, Moreno A. Etiology andoutcome of community-acquired pneumonia in patients with diabetesmellitus. Chest. 2005;128:3233-3239. (Pubitemid 41698645)
12. Fernandez-Sabe N, Carratala J, Roson B, Dorca J, Verdaguer R, ManresaF, Gudiol F. Community-acquired pneumonia in very elderly patients:causative organisms, clinical characteristics, and outcomes. Medicine(Baltimore). 2003;82:159-169. (Pubitemid 36578705)
13. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE,Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identifylow-risk patients with community-acquired pneumonia. N Engl J Med.1997;336:243-250. (Pubitemid 27044625)
14. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA,Kapoor WN. Prognosis and outcomes of patients withcommunity-acquired pneumonia. A meta-analysis. JAMA.1996;275:134-141.
15. Fisman DN, Abrutyn E, Spaude KA, Kim A, Kirchner C, Daley J. Priorpneumococcal vaccination is associated with reduced death,complications, and length of stay among hospitalized adults withcommunity-acquired pneumonia. Clin Infect Dis. 2006;42:1093-1101.
16. Gallacher SJ, Thomson G, Fraser WD, Fisher BM, Gemmell CG,MacCuish AC. Neutrophil bactericidal function in diabetes mellitus:evidence for association with blood glucose control. Diabet Med.1995;12:916-920.
17. Garcia-Vidal C, Ardanuy C, Tubau F, Viasus D, Dorca J, Linares J,Gudiol F, Carratala J. Pneumococcal pneumonia presenting with septicshock: host-and pathogen-related factors and outcomes. Thorax.2010;65:77-81.
18. Garcia-Vidal C, Carratala J, Fernandez-Sabe N, Dorca J, Verdaguer R,Manresa F, Gudiol F. Aetiology of, and risk factors for, recurrentcommunity- acquired pneumonia. Clin Microbiol Infect.2009;15:1033-1038.
19. Garcia-Vidal C, Fernandez-Sabe N, Carratala J, Diaz V, Verdaguer R,Dorca J, Manresa F, Gudiol F. Early mortality in patients withcommunity-acquired pneumonia: causes and risk factors. Eur Respir J.2008;32:733-739.
20. Halm EA, Fine MJ, Marrie TJ, Coley CM, Kapoor WN, Obrosky DS,Singer DE. Time to clinical stability in patients hospitalized withcommunity-acquired pneumonia. Implications for practice guidelines.JAMA. 1998;279:1452-1457. (Pubitemid 28228202)
21. Imaz A, Falco V, Penaranda M, Jordano Q, Martinez X, Nadal C, CurranA, Planes AM, Dalmau D, Ribera E, Riera M, Ruiz de Gopegui E,Pahissa A. Impact of prior pneumococcal vaccination on clinicaloutcomes in HIV-infected adult patients hospitalized with invasivepneumococcal disease. HIV Med. 2009;10:356-363.
22. Johnstone J, Marrie TJ, Eurich DT, Majumdar SR. Effect ofpneumococcal vaccination in hospitalized adults withcommunity-acquired pneumonia. Arch Intern Med. 2007;167:1938-1943. (Pubitemid 47606632)
23. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections inpatients with diabetes mellitus. N Engl J Med. 1999;341:1906-1912.
24. Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA.Hyperglycemic crisis in adult patients with diabetes: a consensusstatement from the American Diabetes Association. Diabetes Care.2006;29:2739-2748. (Pubitemid 44912212)
25. Kornum J, Thomsen R, Riis A, Lervang HH, Schonheyder HC, SorensenHT. Diabetes, glycemic control, and risk of hospitalization withpneumonia. Diabetes Care. 2008;8:1541-1545.
26. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schonheyder HC,Sorensen HT. Type 2 Diabetes and pneumonia outcomes.Diabetes Care. 2007;30:2251-2257.
27. Koziel H, Koziel M. Pulmonary complications of diabetes mellitus.Infect Dis Clin North Am. 1995;9:65-95.
28. Lipsky BA, Boyko EJ, Inui TS, Koepsell TD. Risk factors for acquiringpneumococcal infections. Arch Intern Med. 1986;146:2179-2185.
29. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD,Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, Torres A, Whitney CG. Infectious Disease Society of America/AmericanThoracic Society consensus guidelines on the management ofcommunity-acquired pneumonia in adults. Clin Infect Dis.2007;44(Suppl 2):S27YS72.
30. Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines forpreventing pneumococcal infection in adults. Cochrane Database SystRev. 2008;(1):CD000422.
31. Muchova J, Liptakova A, Orszaghova Z, Garaiova I, Tison P, Carsky J,Durackova Z. Antioxidant systems in polymorphonuclear leucocytesof type 2 diabetes mellitus. Diabet Med. 1999;16:74-78. (Pubitemid 29147227)
32. Musher D, Rueda A, Kaka A, Mapara S. The association betweenpneumococcal pneumonia and acute cardiac events. Clin Infect Dis.2007;45:158-165. (Pubitemid 47041005)
33. Mykietiuk A, Carratala J, Dominguez A, Manzur A, Fernandez-Sabe N,Dorca J, Tubau F, Manresa F, Gudiol F. Effect of prior pneumococcalvaccination on clinical outcome of hospitalized adults withcommunity-acquired pneumococcal pneumonia. Eur J Clin MicrobiolInfect Dis. 2006;25:457-462. (Pubitemid 44078598)
34. Novack V, Macfadyen J, Malhotra A, Almog Y, Glynn RJ, Ridker PM.The effect of rosuvastatin on incident pneumonia: results from theJUPITER trial. CMAJ. 2012;184:E367YE372.
35. Perry T, Pugh M, Waterer G, Nakashima B, Orihuela C, Copeland L,Restrepo M, Anzueto A, Mortensen E. Incidence of cardiovascularevents after hospital admission for pneumonia. Am J Med.2011;124:244-251.
36. Ramirez J, Aliberti S, Mirsaeidi M, Peyrani P, Filardo G, Amir A, MoffettB, Gordon J, Blasi F, Bordon J. Acute myocardial infarction inhospitalized patients with community-acquired pneumonia. Clin InfectDis. 2008;15:182-187. (Pubitemid 351920618)
37. Viasus D, Garcia-Vidal C, Gudiol F, Carratala J. Statins forcommunity-acquired pneumonia: current state of the science. Eur J ClinMicrobiol Infect Dis. 2010;29:143-152.
38. Yende S, van der Poll T, Lee M, Huang DT, Newman AB, Kong L,Kellum JA, Harris TB, Bauer D, Satterfield S, Angus DC; GenIMS andHealth ABC study. The influence of pre-existing diabetes mellitus onthe host immune response and outcome of pneumonia: analysis of twomulticentre cohort studies. Thorax. 2010;65:870-877.